Results
|
25681.
|
|
|
25682.
|
|
|
25683.
|
|
|
25684.
|
|
|
25685.
|
|
|
25686.
|
|
|
25687.
|
|
|
25688.
|
|
|
25689.
|
|
|
25690.
|
|
|
25691.
|
Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS). [electronic resource] by
- Koga, Hirofumi
- Naito, Seiji
- Ishiyama, Hiromichi
- Yorozu, Atsunori
- Saito, Shiro
- Kojima, Shinsuke
- Higashide, Satoshi
- Kikuchi, Takashi
- Nakamura, Katsumasa
- Dokiya, Takushi
- Fukushima, Masanori
Producer: 20200420
In:
Brachytherapy vol. 18
Availability: No items available.
|
|
25692.
|
|
|
25693.
|
|
|
25694.
|
|
|
25695.
|
Commentary on "denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomized, placebo-controlled trial." M.R. Smith, F. Saad, R. Coleman, N. Shore, K. Fizazi, B. Tombal, K. Miller, P. Sieber, L. Karsh, R. Damião, T.L. Tammela, B. Egerdie, H. Van Poppel, J. Chin, J. Morote, F. Gómez-Veiga, T. Borkowski, Z. Ye, A. Kupic, R. Dansey, C. Goessl, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.: Lancet 2012;379:39-46 [Epub;2011, November 15]. [electronic resource] by Producer: 20130405
In:
Urologic oncology vol. 30
Availability: No items available.
|
|
25696.
|
|
|
25697.
|
|
|
25698.
|
|
|
25699.
|
|
|
25700.
|
|